Skip to content
HTGC

Hercules Capital, Inc.

Hercules Capital, Inc. Q3 FY2025 earnings call

October 31, 2025 · fiscal period ended 2025-09

EPS · actual vs est

/

Revenue · actual vs est

/
Ask about this call

Summary

Generated 2025-10-31

Management highlights

  • Hercules had strong Q3 performance with record fundings, investment income, and originations.
  • Maintained balance sheet strength with high first lien exposure above 90%, GAAP leverage at 99.5% in Q3.
  • Originations balanced between life sciences (54% of commitments, 50% of fundings) and tech (46% of commitments, 50% of fundings), added 7 new borrowers in Q3.
  • Exit activity in portfolio with 4 M&A events and 1 IPO year-to-date.
  • PIK income in Q3 was approximately 10.5% of total revenue, 85% from original underwriting, nearly 90% from loans rated 1, 2, or 3.
View in transcript ↓

Segment performance

In Q3 2025, Hercules Capital originated total gross debt and equity commitments of $846.2 million and record gross fundings of $504.6 million. For the first 3 quarters of 2025, record originations were $2.87 billion, with net debt portfolio growth of over $557.8 million. Total investment income in Q3 was a record $138.1 million, net investment income was $88.6 million or $0.49 per share. Period ending assets under management were approximately $5.5 billion, an increase of 20.7% year-over-year. NAV per share in Q3 was $12.05, an increase of 1.8% from Q2 2025.

View in transcript ↓

Guidance

  • Expect origination activity to remain strong through year-end.
  • Q4 expected prepayments in $150 million to $200 million range.
  • Core yield for Q4 expected 12% to 12.5%.
  • SG&A expenses for Q4 expected $25 million to $26 million, RIA dividend approximately $2 million to $2.5 million per quarter.
View in transcript ↓

Risks

  • Pockets of frothiness in venture and growth stage lending markets with deals lacking strong structure and outside prudent underwriting metrics.
  • Market volatility and ongoing government shutdown affecting portfolio monitoring.
View in transcript ↓

Q&A highlights

Q: Brian McKenna asked about the supplemental dividend and credit quality.

A: Scott Bluestein said it's premature to specify supplemental distribution for next year but math is accurate, and credit quality is due to experienced investment team.

Q: Finian O'Shea inquired about adviser expense allocation.

A: Seth Meyer stated expense allocation drifts with AUM and originations.

Q: Crispin Love asked about credit quality and rate cuts impact.

A: Scott Bluestein mentioned consistent conservative underwriting, Seth Meyer noted ~60% of prime-based loans at contractual floor affecting NII.

Q: Douglas Harter asked about frothiness in deals.

A: Scott Bluestein said issues with deal structure and funding amounts.

Q: John Hecht asked about AI impact and market share.

A: Scott Bluestein talked about short portfolio duration and taking market share.

Q: Christopher Nolan asked about blockchain use.

A: Scott Bluestein said not using blockchain for tracking investments.

Q: Paul Johnson asked about unrealized gains.

A: Scott Bluestein broke down unrealized gains in debt portfolio.

Q: Paul Johnson asked about PIK in venture loans.

A: Scott Bluestein explained PIK usage in underwriting, typically small part of interest.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS
Revenue

Transcript

October 31, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.